top of page

Negative symptoms Impacting Quality of Life and Functioning
 

Presented By: 

Ofer Agid, MD

Associate Professor, Department of Psychiatry

CAMH and the University of Toronto

Toronto, ON

​

Christoph Correll, MD

Professor of Psychiatry and Molecular Medicine
The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

Hempstead, NY

​

Ric Procyshyn, BSc(Pharm), MSc, PharmD, PhD

University of British Columbia

Principal Investigator

BC Mental Health and Substance Use Services Research Institute

Vancouver, BC

Originally Presented at 2022 Negative Symptoms Webinar​​​

Learning Objectives: 

  • ​Consider the impact of negative symptoms on functioning and quality of life

  • Evaluate the pharmodynamic and pharmacokinetic profile of antipsychotic medications in relation to negative symptoms and side effect burden

  • Identify appropriate patients whose treatment plan should be re-evaluated in order to optimize care

This initiative has been sponsored in part by Abbvie, through an educational grant.

Canadian Consortium for

Early Intervention in Psychosis​​

​

Hamilton, ON

905-525-8213

Contact Us: admin@epicanada.org​

  • LinkedIn
  • X

Become a Friend of EPI Canada!

© 2026, Canadian Consortium for Early Intervention in Psychosis

bottom of page